USA Volleyball Women’s National Team Speaks Out Against Olympic Genetic Testing

The Statement That Rocked the Olympic World

On June 16, 2026, the athletes of the USA Women’s National Volleyball Team went public with their objections to the IOC’s mandatory genetic screening policy, calling it “invasive biological testing” and demanding transparency about how their most sensitive personal data would be handled.

The statement was measured but firm. It was not a refusal to comply — the athletes had already undergone the required testing. It was a demand for basic protections: privacy, transparency, due process, and dignity.

The Exact Words from the Athletes

“The IOC has mandated genetic testing for all female athletes who may participate in Olympic events. The athletes of the USA Women’s National Team have complied with the SRY testing requirements as administered by the FIVB. However, we feel compelled to formally express our significant concerns regarding both the process and implementation of this policy.”

The athletes listed four concerns: they were asked to undergo testing without sufficient transparency about how their genetic data would be handled; they were not informed where the data would be stored, who would have access, how it would be protected, or how long it would be retained; there is no independent appeals process for disputed or false-positive findings; and the policy lacks confirmatory procedures and athlete safeguards.

The statement closed: “This statement is not about resisting accountability or refusing compliance. It is about asserting that athletes deserve the same standards of medical privacy, procedural fairness, transparency, and dignity expected in any professional environment involving sensitive health and genetic information.”

What the IOC Policy Actually Requires

The IOC adopted its Policy on the Protection of the Female (Women’s) Category on March 26, 2026. It requires SRY gene screening for all female athletes starting with the 2028 LA Olympics. A positive SRY test results in exclusion from the female category unless the athlete has Complete Androgen Insensitivity Syndrome or a similarly rare condition. The IOC states the test is more than 99% accurate, but critics note it is a screening tool, not a diagnostic.

The FIVB’s Role

The FIVB Board of Administration approved case-by-case SRY testing on February 27, 2026. Each National Federation must provide test results for every player beginning in the 2026 season.

A Troubled History

From the late 1960s to 1999, the IOC required chromosome testing for all female athletes. The practice was abandoned due to inaccuracies, cost, and psychological trauma. The American Medical Association and the government of Norway opposed it. SRY screening is currently illegal in Norway and France.

Who Else Is Speaking Out

Caster Semenya called the policy “a disgrace” in Time magazine. WNBA star Brianna Turner published an op-ed opposing it. Veronica Ivy, two-time world champion cyclist, called it “heartbreaking.”

FAQ

What is SRY testing?

A genetic screening test for the SRY gene on the Y chromosome that initiates male sex development.

When does the policy take effect?

The 2028 Los Angeles Olympics. Not retroactive.

Did the team comply?

Yes. They raised concerns about process, not refused the tests.

Want to build mental resilience? VBallStars offers free science-backed mental performance tools for athletes at every level.